GS
Gagnon Securities’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.8M | Buy |
368,353
+60,019
| +19% | +$1.43M | 1.79% | 24 |
|
2025
Q1 | $7.66M | Sell |
308,334
-13,409
| -4% | -$333K | 1.69% | 23 |
|
2024
Q4 | $6.06M | Buy |
321,743
+14,800
| +5% | +$279K | 1.22% | 26 |
|
2024
Q3 | $4.62M | Sell |
306,943
-289,648
| -49% | -$4.36M | 0.92% | 33 |
|
2024
Q2 | $17.1M | Buy |
596,591
+47,623
| +9% | +$1.36M | 3.84% | 5 |
|
2024
Q1 | $16M | Buy |
548,968
+3,389
| +0.6% | +$99K | 3.8% | 5 |
|
2023
Q4 | $18.4M | Sell |
545,579
-19,850
| -4% | -$670K | 4.42% | 5 |
|
2023
Q3 | $17.3M | Buy |
565,429
+6,220
| +1% | +$191K | 4.35% | 5 |
|
2023
Q2 | $22.4M | Sell |
559,209
-2,501
| -0.4% | -$100K | 4.66% | 4 |
|
2023
Q1 | $22.9M | Sell |
561,710
-1,705
| -0.3% | -$69.6K | 4.82% | 4 |
|
2022
Q4 | $21.8M | Sell |
563,415
-11,193
| -2% | -$432K | 4.8% | 3 |
|
2022
Q3 | $30.6M | Sell |
574,608
-19,784
| -3% | -$1.05M | 6.72% | 1 |
|
2022
Q2 | $34.7M | Sell |
594,392
-16,541
| -3% | -$964K | 7.26% | 1 |
|
2022
Q1 | $46.6M | Sell |
610,933
-2,857
| -0.5% | -$218K | 7.6% | 1 |
|
2021
Q4 | $36.9M | Buy |
613,790
+43,147
| +8% | +$2.6M | 5.54% | 4 |
|
2021
Q3 | $32M | Buy |
570,643
+71,310
| +14% | +$3.99M | 4.75% | 3 |
|
2021
Q2 | $30.3M | Buy |
499,333
+44,484
| +10% | +$2.7M | 4.3% | 5 |
|
2021
Q1 | $31.9M | Buy |
454,849
+19,894
| +5% | +$1.39M | 4.85% | 4 |
|
2020
Q4 | $26M | Buy |
434,955
+9,288
| +2% | +$556K | 4.14% | 6 |
|
2020
Q3 | $25.6M | Buy |
425,667
+3,526
| +0.8% | +$212K | 5.46% | 3 |
|
2020
Q2 | $22.2M | Buy |
422,141
+14,982
| +4% | +$786K | 5.36% | 3 |
|
2020
Q1 | $13.7M | Buy |
407,159
+21,247
| +6% | +$712K | 4.64% | 5 |
|
2019
Q4 | $17.5M | Sell |
385,912
-1,467
| -0.4% | -$66.5K | 3.83% | 7 |
|
2019
Q3 | $14.7M | Buy |
387,379
+108,766
| +39% | +$4.14M | 3.49% | 8 |
|
2019
Q2 | $12.1M | Buy |
+278,613
| New | +$12.1M | 2.61% | 14 |
|